bioAffinity Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.About BIAF
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells.
CEOMaria Zannes
CEOMaria Zannes
Employees57
Employees57
HeadquartersSan Antonio, Texas
HeadquartersSan Antonio, Texas
Founded2014
Founded2014
Employees57
Employees57
BIAF Key Statistics
Market cap5.67M
Market cap5.67M
Price-Earnings ratio-0.06
Price-Earnings ratio-0.06
Dividend yield—
Dividend yield—
Average volume72.51K
Average volume72.51K
High today$1.28
High today$1.28
Low today$1.22
Low today$1.22
Open price$1.26
Open price$1.26
Volume43.07K
Volume43.07K
52 Week high$46.53
52 Week high$46.53
52 Week low$1.11
52 Week low$1.11
Stock Snapshot
As of today, bioAffinity Technologies(BIAF) shares are valued at $1.28. The company's market cap stands at 5.67M, with a P/E ratio of -0.06.
On 2026-01-14, bioAffinity Technologies(BIAF) stock traded between a low of $1.22 and a high of $1.28. Shares are currently priced at $1.28, which is +5.3% above the low and 0.0% below the high.
bioAffinity Technologies(BIAF) shares are trading with a volume of 43.07K, against a daily average of 72.51K.
In the last year, bioAffinity Technologies(BIAF) shares hit a 52-week high of $46.53 and a 52-week low of $1.11.
In the last year, bioAffinity Technologies(BIAF) shares hit a 52-week high of $46.53 and a 52-week low of $1.11.
People also own
Based on the portfolios of people who own BIAF. This list is generated using Robinhood data, and it’s not a recommendation.